Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.1B bought by 553 insiders at 344 companies
- $9.7B sold by 664 insiders outside a trading plan
- $4.6B sold by 964 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
DELLDell Technologies Inc.Silver Lake Partners IV, L.P.Director · +4 joint filers$356M
-
DELLDell Technologies Inc.Sl Spv-2, L.P.Director · +4 joint filers$289M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Viviane Monges DirectorPHVSPharvaris N.V.Sale$396K 11,969 shares at $33.05 69% of stakeTraded Sep 23 Filed Sep 25
-
Jennifer Cope EVP Ops Services & Risk MgmtCBLCBL & Associates Properties, Inc.Sale$352K 6,763 shares at $52.00 22% of stakeTraded Sep 24 Filed Sep 25
-
Japan Post Holdings Co., Ltd. 10% ownerAFLAflac IncorporatedPlanned sale$1.6M 13,500 shares at $115.20 <0.1% of stakeTraded Sep 23 Filed Sep 25
-
Or Offer CEOSMWBSimilarweb Ltd.Planned sale$879K 114,300 shares at $7.69 2.8% of stakeTraded Sep 24 Filed Sep 25
-
Yanjun Wang CCO and GCSESea LimitedPlanned sale$245K 2,400 shares at $102.05 2.5% of stakeTraded Sep 23–24 Filed Sep 25
-
Brian Taylor Slingsby DirectorMLYSMineralys Therapeutics, Inc.Sale$3M 104,320 shares at $28.81 1.3% of stakeTraded Sep 22 Filed Sep 24
-
Kang Jyh Lee DirectorPLABPhotronics, Inc.Sale$297K 10,000 shares at $29.70 2.7% of stakeTraded Sep 22 Filed Sep 24
-
David J. Borges VP, Finance & CAOOMEROmeros CorporationPlanned sale$419K 20,000 shares at $20.95 100% of stakeTraded Sep 22–23 Filed Sep 24
-
Koch, Inc. 10% owner · +1 joint filerASPNAspen Aerogels, Inc.Sale$58.1M 12.3M shares at $4.73 100% of stakeTraded Sep 23 Filed Sep 24
-
David A Duffield 10% ownerWDAYWorkday, Inc.Planned sale$19.1M 99,613 shares at $192.14 49% of stakeTraded Sep 23 Filed Sep 24
-
Mark S Demilio DirectorRHRhSale$132K 1,000 shares at $132.00 3.7% of stakeTraded Sep 22 Filed Sep 24
-
Susan Butenhoff DirectorOOMAOoma, Inc.Sale$198K 9,000 shares at $22.03 7.6% of stakeTraded Sep 22 Filed Sep 24
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.1M 20,000 shares at $253.17 0.3% of stakeTraded Sep 22–23 Filed Sep 24
-
Jessica Newcomb Principal Accounting OfficerTNGXTango Therapeutics, Inc.Planned sale$199K 8,200 shares at $24.22 12% of stakeTraded Sep 22 Filed Sep 24
-
Robert P Rozek CFOKFYKorn FerrySale$278K 3,709 shares at $75.03 2.3% of stakeTraded Sep 23 Filed Sep 24
-
Michael N Intrator CEOCRWVCoreWeave, Inc.Planned sale$26.7M 307,692 shares at $86.82Traded Sep 22 Filed Sep 24
-
Nitin Agrawal CFOCRWVCoreWeave, Inc.Planned sale$4.8M 55,764 shares at $86.83 30% of stakeTraded Sep 22 Filed Sep 24
-
Jennifer Newstead SVP, GC and Government AffairsAAPLApple Inc ComPlanned sale$816K 2,399 shares at $340.06 5.1% of stakeTraded Sep 22 Filed Sep 24
-
Elizabeth M Anderson DirectorRVMDRevolution Medicines, Inc.Planned sale$2M 10,143 shares at $193.04 70% of stakeTraded Sep 22 Filed Sep 24
-
Benoit Dageville DirectorSNOWSnowflake Inc.Planned sale$17M 50,000 shares at $339.08 2% of stakeTraded Sep 23 Filed Sep 24
-
Jonathan Mead Beaulier Chief Revenue OfficerSNOWSnowflake Inc.Sale$254K 755 shares at $336.36 0.4% of stakeTraded Sep 23 Filed Sep 24
-
James R. Kasinger General Counsel and SecretaryCRSPCRISPR Therapeutics AGPlanned sale$626K 10,400 shares at $60.24 9.9% of stakeTraded Sep 22 Filed Sep 24
-
Todd C Cooper PresidentCLSCelestica, Inc.Planned sale$7.2M 20,118 shares at $360.00 22% of stakeTraded Sep 23 Filed Sep 24
-
Robert Mionis CEOCLSCelestica, Inc.Planned sale$8.5M 23,396 shares at $364.22 100% of stakeTraded Sep 23 Filed Sep 24
-
ISQ Global Fund II GP LLC 10% owner · +4 joint filersKNTKKinetik Holdings Inc.Sale$3.4M 64,131 shares at $53.66 14% of stakeTraded Sep 22–23 Filed Sep 24
-
Diane M Gershowitz DirectorMCSMarcus Corporation (The)Sale$1.4M 50,000 shares at $27.61 29% of stakeTraded Sep 23 Filed Sep 24
-
Todd McKinnon CEOOKTAOkta, Inc.Planned sale$9.4M 48,822 shares at $193.48 100% of stakeTraded Sep 22 Filed Sep 24
-
Salvatore Privitera Chief Technical OfficerATRCAtriCure, Inc.Planned sale$271K 4,519 shares at $60.00 3.1% of stakeTraded Sep 23 Filed Sep 24
-
Richard L Hardgrove DirectorSBFGSB Financial Group, Inc.Sale$108K 3,702 shares at $29.08 26% of stakeTraded Sep 15 Filed Sep 24
-
Vladimir Tenev CEOHOODRobinhood Markets, Inc.Planned sale$30.2M 240,834 shares at $125.33 100% of stakeTraded Sep 22 Filed Sep 24
-
Andrew J. Schwab DirectorSKYESkye Bioscience, Inc.Sale$240K 148,079 shares at $1.62 100% of stakeTraded Sep 22–23 Filed Sep 24
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $491.57 2.8% of stakeTraded Sep 23 Filed Sep 24
-
Shehnaaz Suliman DirectorTXG10x Genomics, Inc.Planned sale$465K 5,723 shares at $81.19 19% of stakeTraded Sep 22 Filed Sep 24
-
Serge Saxonov CEOTXG10x Genomics, Inc.Planned sale$2M 25,000 shares at $81.22 2.3% of stakeTraded Sep 22 Filed Sep 24
-
James W Wert DirectorPKOHPark-Ohio Holdings Corp.Sale$143K 3,000 shares at $47.50 3.4% of stakeTraded Sep 24 Filed Sep 24
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6.8M 69,000 shares at $99.17 17% of stakeTraded Sep 23–24 Filed Sep 24
-
Kathleen Scarlett Sevp, CHROBBYBest Buy Co., Inc.Sale$10.7M 116,062 shares at $92.15 50% of stakeTraded Sep 23 Filed Sep 24
-
Gary Bowman CEOBWMNBowman Consulting Group Ltd.Planned sale$2.6M 60,000 shares at $42.55Traded Sep 23 Filed Sep 24
-
John Colgrove Chief Visionary OfficerPEverpure, Inc.Planned sale$22.7M 200,000 shares at $113.26 100% of stakeTraded Sep 22–24 Filed Sep 24
-
Michael Lane Executive Vice PresidentSEICSEI Investments CompanySale$247K 2,400 shares at $102.78 5.7% of stakeTraded Sep 22 Filed Sep 24
-
Eric P Lefkofsky CEOTEMTempus AI, Inc.Planned sale$19.4M 250,000 shares at $77.47 71% of stakeTraded Sep 22 Filed Sep 24
-
Gwynne Shotwell COOSPCXSpace Exploration Technologies (SpaceX)Planned sale$52.5M 342,170 shares at $153.57 12% of stakeTraded Sep 22 Filed Sep 24
-
Christopher Hite ChairRPRXRoyalty Pharma plcPlanned sale$5.9M 100,000 shares at $58.53 27% of stakeTraded Sep 22 Filed Sep 24
-
Jonathan Shar CEOBNEDBarnes & Noble Education, IncSale$331K 30,000 shares at $11.04 8.4% of stakeTraded Sep 22 Filed Sep 24
-
Lynn Vojvodich Radakovich DirectorDELLDell Technologies Inc.Planned sale$1.1M 2,022 shares at $565.28 7.4% of stakeTraded Sep 22 Filed Sep 24
-
Japan Post Holdings Co., Ltd. 10% ownerAFLAflac IncorporatedPlanned sale$1.4M 12,200 shares at $114.55 <0.1% of stakeTraded Sep 22 Filed Sep 24
-
Akos Czibere Chief Medical OfficerAKTSAktis Oncology, Inc.Planned sale$259K 12,500 shares at $20.69 100% of stakeTraded Sep 23 Filed Sep 24
-
Michael Kiernan Chief Revenue OfficerNXDRNextdoor Holdings, Inc.Planned sale$127K 50,000 shares at $2.54 9.8% of stakeTraded Sep 22 Filed Sep 24
-
Morgan Fong Chief Legal OfficerCARTMaplebear Inc.Planned sale$827K 18,390 shares at $44.98 3.4% of stakeTraded Sep 22 Filed Sep 24
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.